SCHEMBL4906798

SCHEMBL4906798

COC(=O)c1cc(S(=O)(=O)NCCc2ccc(OCc3c(F)cccc3Cl)cc2)cc(C)c1C

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.43
LMNA P02545 4/20 0.43
RECQL P46063 1/20 0.43
KDM4E B2RXH2 1/20 0.42
XBP1 P17861 1/20 0.42
AKR1C3 P42330 1/20 0.42
TP53 P04637 3/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ERBB2 P04626 1/20 0.41
ERBB4 Q15303 1/20 0.41
TBXA2R P21731 1/20 0.41
TBXAS1 P24557 1/20 0.41
ALDH1A1 P00352 2/20 0.41
POLB P06746 1/20 0.40
MCOLN3 Q8TDD5 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SGMS1 Q86VZ5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4907048 0.92 MAPT (0.46) MAPTLMNARECQLKDM4EXBP1
SCHEMBL4905824 0.92 MAPT (0.50) MAPTLMNARECQLKDM4EXBP1
SCHEMBL4908765 0.87 MAPT (0.47) MAPTLMNARECQLKDM4EXBP1
SCHEMBL4895653 0.86 AKR1C3 (0.43) MAPTLMNAAKR1C3TP53MEN1
SCHEMBL4895953 0.85 MAPT (0.52) MAPTLMNARECQLKDM4EXBP1
SCHEMBL4911868 0.84 MAOA (0.45) MAPTLMNARECQLAKR1C3TP53
SCHEMBL4904027 0.84 ALDH1A1 (0.53) MAPTAKR1C3ERBB2ERBB4TBXA2R
SCHEMBL4908016 0.83 MMP2 (0.49) MAPTLMNAAKR1C3TP53MEN1
SCHEMBL4900677 0.83 AKR1C3 (0.46) AKR1C3MEN1KMT2AERBB2ERBB4
SCHEMBL4899280 0.82 MAPT (0.48) MAPTLMNARECQLKDM4EXBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD MAPT 1858/4885LMNA 317/4885RECQL 4182/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MAPT 1786/4885LMNA 319/4885RECQL 4170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.